02616.HK
CStone Pharmaceuticals
HKSE · Healthcare · Biotechnology · CN
HKD 5.34
−0.84%Leverage
- Debt / equity
- 0.28x
- Net debt / equity
- -0.80x
- Debt / assets
- 0.17x
- Debt / EBITDA
- -1.04x
- Net debt / EBITDA
- 3.02x
Liquidity & coverage
- Current ratio
- 3.58x
- Quick ratio
- 3.44x
- Cash ratio
- 3.09x
- Interest coverage
- -34.30x
- EBITDA / interest
- -30.36x
- Working capital
- HKD 1.5B
Cash & dividend
- FCF / debt
- -0.16x
- Cash flow / debt
- -0.16x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026